Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808833 · ClinicalTrials.gov registry record
Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01808833 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 4 participants.
The verdict
NCT01808833 was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The investigators hypothesize that frailty assessment prior to concurrent chemotherapy and radiation therapy in the elderly will predict treatment-related toxicity and morbidity and that such assessment at serial time points will help improve treatment and outcomes for these patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01808833
The ClinicalTrials.gov registry entry for NCT01808833 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01808833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01808833 about?
NCT01808833 is a clinical study titled "Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy". The investigators hypothesize that frailty assessment prior to concurrent chemotherapy and radiation therapy in the elderly will predict treatment-related toxicity and morbidity and that such assessment at serial time points will help improve treatment and outcomes for these patients.
What is the current status of trial NCT01808833?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2012-02. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT01808833?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.